Co‐Solvent Engineering Contributing to Achieve High‐Performance Perovskite Solar Cells and Modules Based on Anti‐Solvent Free Technology
Small · 2023-07 · 19 (28)
DOI: 10.1002/smll.202301323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 29.03.2023. Verfasst von Gu Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Advanced Materials & Guangdong Provincial Key Laboratory of Optical, Information Materials and Technology, South China Academy of Advan…. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: NSFC, Guangdong Basic and Applied Basic Research, Science and Technology Programs of Guangzhou.
Abstract (Originalsprache)
The pinhole‐free and defect‐less perovskite film is crucial for achieving high efficiency and stable perovskite solar cells (PSCs), which can be prepared by widely used anti‐solvent crystallization strategies. However, the involvement of anti‐solvent requires precise control and inevitably brings toxicity in fabrication procedures, which limits its large‐scale industrial application. In this work, a facile and effective co‐solvent engineering strategy is introduced to obtain high‐ quality perovskite film while avoiding the usage of anti‐solvent. The uniform and compact perovskite polycrystalline films have been fabricated through the addition of co‐solvent that owns strong coordination capacity with perovskite components , meanwhile possessing the weaker interaction with main solvent . With those strategies, a champion power conversion efficiency (PCE) of 22% has been achieved with the optimal co‐solvent, N‐methylpyrrolidone (NMP) and without usage of anti‐solvent. Subsequently, PSCs based on NMP show high repeatability and good shelf stability (80% PCE remains after storing in ambient condition for 30 days). Finally, the perovskite solar module (5 × 5 cm) with 7 subcells connects in series yielding champion PCE of 16.54%. This strategy provides a general guidance of co‐solvent selection for PSCs based on anti‐solvent free technology and promotes commercial application of PSCs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Advanced Materials & Guangdong Provincial Key Laboratory of Optical, Information Materials and Technology, South China Academy of Advanced, Optoelectronics, South China Normal University, Guangzhou, 510006…
- Guangdong Provincial Key Laboratory of Optical Information Materials and, Technology & Institute of Electronic Paper Displays, South China Academy of Advanced Optoelectronics, South China Normal University, Guangzhou, 5…
- Department of Advanced Design and Systems Engineering, City University of Hong Kong, Hong Kong, 999077, China.
- Laboratory of Solid-State Microstructures, Nanjing University, Nanjing, 210093, China.
ORCID-Profile: Zhen Wang, Yancong Feng, Jinwei Gao
Förderung
- NSFC
- Guangdong Basic and Applied Basic Research
- Science and Technology Programs of Guangzhou
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Li, G., Wang, Z., Wang, Y., Yang, Z., Dong, P., Feng, Y., Jiang, Y., Feng, S. P., Zhou, G., Liu, J. M., & Gao, J. (2023). Co‐Solvent Engineering Contributing to Achieve High‐Performance Perovskite Solar Cells and Modules Based on Anti‐Solvent Free Technology. Small, 19(28). https://doi.org/10.1002/smll.202301323
Vancouver
Li G, Wang Z, Wang Y, Yang Z, Dong P, Feng Y, et al. Co‐Solvent Engineering Contributing to Achieve High‐Performance Perovskite Solar Cells and Modules Based on Anti‐Solvent Free Technology. Small. 2023;19(28). doi:10.1002/smll.202301323
BibTeX
@article{Li2023,
author = {Li, Gu and Wang, Zhen and Wang, Yuqi and Yang, Zhengchi and Dong, Pengyu and Feng, Yancong and Jiang, Yue and Feng, Shien-Ping and Zhou, Guofu and Liu, Jun-Ming and Gao, Jinwei},
title = {Co‐Solvent Engineering Contributing to Achieve High‐Performance Perovskite Solar Cells and Modules Based on Anti‐Solvent Free Technology},
journal = {Small},
year = {2023},
volume = {19},
number = {28},
doi = {10.1002/smll.202301323}
}
EUVIMED